National Stroke Foundation


The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Approval Status:

Approved September 1997

Specific Treatments:

Treatment for chemotherapy induced emesis

Therapeutic Areas

General Information

Anzemet has been approved for the prevention of chemotherapy-induced nausea and vomiting, and prevention of postoperative nausea and vomiting.